We are currently investigating a rodent study by using apolipoprotein E-knockout (apoE KO) mice as our mice model to induce atherosclerosis and identify the role of the LPL inhibitor NDGA on CVD risk and HDL subpopulations. The gene discussed is LPL; the disease is atherosclerosis.